2021
DOI: 10.1016/j.amjcard.2021.01.033
|View full text |Cite
|
Sign up to set email alerts
|

Meta-Analysis of Population Characteristics and Outcomes of Patients Undergoing Pericardiectomy for Constrictive Pericarditis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 25 publications
0
14
0
Order By: Relevance
“…The effectiveness of treatment with corticosteroids in TP remains controversial. Steroids have not yet been found to have overwhelming beneficial effects on reabsorption of pericardial effusion or in the progression to constrictive pericarditis[ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…The effectiveness of treatment with corticosteroids in TP remains controversial. Steroids have not yet been found to have overwhelming beneficial effects on reabsorption of pericardial effusion or in the progression to constrictive pericarditis[ 23 ].…”
Section: Discussionmentioning
confidence: 99%
“…However, most of the studies represented single-center and retrospective experiences. Tzani, A. et al performed a meta-analysis to systematically review the clinical outcomes of patients undergoing pericardiectomy for constrictive pericarditis [21]. This meta-analysis included 27 eligible studies and 2,114 patients.…”
Section: Discussionmentioning
confidence: 99%
“…The mainstay and only treatment available for CP is pericardiectomy. 5 An observational study conducted over a 20-year period on 99 patients in Montreal showed 7.9% hospital mortality for isolated pericardiectomy. Surgical intervention within 6 months of the onset of symptoms was associated with reduced hospital mortality (odds ratio 0.11).…”
Section: Discussionmentioning
confidence: 99%
“…Our patient was not on steroids on admission, which is the most commonly used adjunctive therapy for tuberculous pericarditis. 5 , 8 To date, the largest trial of its use is the ‘investigation of the management of pericarditis trial’ that showed no significant difference in the composite of death, cardiac tamponade requiring pericardiocentesis, or CP between patients who received prednisolone and those who received placebo (23.8% and 24.5%, respectively; hazard ratio 0.95, 95% confidence interval 0.77–1.18; P = 0.66). 9 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation